By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
Dicerna (DRNA) Prioritizes Resources To Advance GalXC Product Candidates 9/26/2016 10:08:40 AM
Dicerna (DRNA) Terminates Development of DCR-PH1, Shifts Focus 9/26/2016 6:14:24 AM
Dicerna (DRNA) To Present At September Investor Conference 9/7/2016 12:51:46 PM
Dicerna (DRNA) Reports Second Quarter 2016 Financial And Operational Results 8/5/2016 10:50:37 AM
Dicerna (DRNA) To Report Second Quarter 2016 Financial Results And Host Conference Call On August 4, 2016 7/29/2016 8:40:43 AM
New Preclinical Data Show Potential Of Dicerna (DRNA) GalXC Subcutaneous Delivery Platform As RNAi Drug Discovery Engine 6/29/2016 9:19:04 AM
Dicerna (DRNA) Appoints Martin Freed, M.D., To Board Of Directors 6/15/2016 8:01:57 AM
Dicerna (DRNA) To Present At The Jefferies 2016 Healthcare Conference 6/3/2016 10:03:05 AM
Dicerna (DRNA) Announces Dosing Of First Patient In Phase 1 Clinical Trial Of DCR-PH1 In Patients With Primary Hyperoxaluria Type 1 (PH1) 5/13/2016 9:09:26 AM
Dicerna (DRNA) Reports Potent Preclinical Activity With GalNAc-DsiRNA-EX Conjugates 5/11/2016 10:51:25 AM